Biotech

Relevium Technologies provided shareholders with a look at the company’s business in their first day of business and their strategy moving forward.

Relevium Technologies (TSXV:RLV) provided shareholders with a look at the company’s business in their first day of business and their strategy moving forward.
As quoted in the press release:

On June 6, 2017, Relevium acquired the assets and business of BioGanix, the Company’s first acquisition of e-retail assets. Management and the previous owner of BioGanix have been working diligently to ensure a smooth transition of the business. Jointly, careful detailed transitioning of the online operations has been ongoing in order to avoid any possible disruptions to the daily business operations.
The Company is happy to announce that the initial transition of the current business has been successful, and Relevium has recorded revenues of approximately CAD$700,000 since closing, representing a 52% increase over the previous period last year (47% increase taking into account the effect of FX fluctuations).
In the month of August, management will be working closely with the previous ownership to optimize operations and making additions to the current product offering.
Aurelio Useche, CEO, stated: “We are extremely pleased with the dedication and professionalism demonstrated by the previous ownership, the staff and our internal team during this initial phase of work.” Mr. Useche continued: “We look forward to this continued partnership as we move into the optimization phase of the transition.”

Click here to read the full press release.

Source: www.marketwired.com

Featured

MARKETS

Markets
TSX20748.58+216.40
TSXV724.19+9.53
DOW33212.96+575.77
S&P 5004158.24+100.40
NASD12131.13+390.48
ASX7182.70+76.80

COMMODITIES

Commodities
Gold1853.48+0.45
Silver22.12+0.03
Copper4.32+0.06
Palladium2076.57+13.05
Platinum957.08+2.92
Oil115.07+0.98
Heating Oil3.90+0.05
Natural Gas8.71-0.19

DOWNLOAD FREE REPORTS

×